Obesity-hypertension: The effects on cardiovascular and renal systems

被引:78
作者
Zhang, RB [1 ]
Reisin, E [1 ]
机构
[1] Louisiana State Univ, Hlth Sci Ctr, Dept Med, Nephrol Sect, New Orleans, LA 70112 USA
关键词
obesity; blood pressure; renal; hemodynamics; cardiovascular disease;
D O I
10.1016/S0895-7061(00)01254-1
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Longitudinal and cross-sectional studies suggest that a large number of obese patients have a high prevalence of hypertension. This association causes the following changes: insulin and leptin resistance with a suppressed biologic activity of natriuretic peptide, which contributes to sodium retention with concomitant expanded cardiopulmonary volume and increased cardiac output. The cellular metabolism of cations may be altered in obesity and may lead to changes in vascular responsiveness and increased vascular resistance. These changes lead to structural adaptations in the heart characterized by concentric-eccentric left ventricular hypertrophy. The hypertrophic condition provides the basis for the development of congestive heart failure and cardiac arrhythmias that may explain the higher rates of cardiac sudden death in those patients. In the kidneys, obesity hypertension may initiate a derangement of renal function. The increased deposit of interstitial cells and of extracellular matrix between the tubules induces higher interstitial hydrostatic pressure and tubular sodium reabsorption. The consequent increase in renal now and glomerular filtration enhances albuminuria excretion and the susceptibility to the development of renal damage. In summary, the hemodynamic and structural adaptations related to obesity hypertension is the cause of greater risk for adverse cardiovascular and renal events. Am J Hypertens 2000;13:1308-1314 (C) 2000 American Journal of Hypertension, Ltd.
引用
收藏
页码:1308 / 1314
页数:7
相关论文
共 59 条
[11]   EXCESSIVE MORTALITY AND CAUSES OF DEATH IN MORBIDLY OBESE MEN [J].
DRENICK, EJ ;
BALE, GS ;
SELTZER, F ;
JOHNSON, DG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1980, 243 (05) :443-445
[12]   SUDDEN-DEATH AS A RESULT OF HEART-DISEASE IN MORBID-OBESITY [J].
DUFLOU, J ;
VIRMANI, R ;
RABIN, I ;
BURKE, A ;
FARB, A ;
SMIALEK, J .
AMERICAN HEART JOURNAL, 1995, 130 (02) :306-313
[13]   Expression of the functional leptin receptor mRNA in pancreatic islets and direct inhibitory action of leptin on insulin secretion [J].
Emilsson, V ;
Liu, YL ;
Cawthorne, MA ;
Morton, NM ;
Davenport, M .
DIABETES, 1997, 46 (02) :313-316
[14]  
FROHLICH ED, 1983, HYPERTENSION, V5, P71
[15]   MEDICAL PROGRESS - THE HEART IN HYPERTENSION [J].
FROHLICH, ED ;
APSTEIN, C ;
CHOBANIAN, AV ;
DEVEREUX, RB ;
DUSTAN, HP ;
DZAU, V ;
FAUADTARAZI, F ;
HORAN, MJ ;
MARCUS, M ;
MASSIE, B ;
PFEFFER, MA ;
RE, RN ;
ROCCELLA, EJ ;
SAVAGE, D ;
SHUB, C .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (14) :998-1008
[16]   Human blood-brain barrier leptin receptor - Binding and endocytosis in isolated human brain microvessels [J].
Golden, PL ;
Maccagnan, TJ ;
Pardridge, WM .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (01) :14-18
[17]   Abnormal kidney function as a cause and a consequence of obesity hypertension [J].
Hall, JE ;
Brands, MW ;
Henegar, JR ;
Shek, EW .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1998, 25 (01) :58-64
[18]   OBESITY-INDUCED HYPERTENSION - RENAL-FUNCTION AND SYSTEMIC HEMODYNAMICS [J].
HALL, JE ;
BRANDS, MW ;
DIXON, WN ;
SMITH, MJ .
HYPERTENSION, 1993, 22 (03) :292-299
[19]  
Halli RW, 1997, ANQ-Q J SHORT ART N, V10, P55
[20]   Receptor-mediated regional sympathetic nerve activation by leptin [J].
Haynes, WG ;
Morgan, DA ;
Walsh, SA ;
Mark, AL ;
Sivitz, WI .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (02) :270-278